NRX Pharmaceuticals NRXP
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 2.71 | -16 | 0 | 2.58 | 13 | |
| 2025Q3 | 3.30 | -26 | -6 | -59.39 | 15 | |
| 2025Q2 | 3.26 | -36 | -18 | -282.91 | 5 | |
| 2025Q1 | 2.05 | -25 | -6 | -98.07 | 8 | |
| 2024Q4 | 2.20 | -23 | -9 | -223.79 | 4 | |
| 2024Q3 | 1.69 | -19 | -2 | -33.37 | 4 | |
| 2024Q2 | 2.44 | -18 | -8 | -174.48 | 5 | |
| 2024Q1 | 4.72 | -15 | -7 | -117.59 | 4 | |
| 2023Q4 | 4.60 | -12 | -4 | -42.42 | 7 | |
| 2023Q3 | 2.60 | -6 | -6 | -36.83 | 13 | |
| 2023Q2 | 4.84 | -3 | -9 | -41.92 | 20 | |
| 2023Q1 | 6.59 | 0 | -11 | -46.39 | 22 | |
| 2022Q4 | 11.10 | 7 | -84.67 | -10 | -40.45 | 26 |
| 2022Q3 | 7.40 | 17 | -43.11 | -9 | -31.73 | 25 |
| 2022Q2 | 6.00 | 25 | -24.48 | -7 | -18.37 | 32 |
| 2022Q1 | 24.50 | 32 | -51.24 | -13 | -35.24 | 44 |
| 2021Q4 | 47.80 | 21 | -207.65 | -30 | -77.99 | 33 |
| 2021Q3 | 92.70 | 8 | -37 | -116.15 | 45 | |
| 2021Q2 | 116.20 | -17 | -16 | -130.28 | 19 | |
| 2021Q1 | 1 | -53.63 | -1 | -14.80 | 6 |